Skip to content

Can pre operative echocardiographic evaluation predict the post operative outcome in OPCAB surgeries.

DESIGNING A NEW SCORING SYSTEM BASED ON ECHOCARDIOGRAPHIC PARAMETERS (ECHO SCORE) AND COMPARING WITH THE EuroSCORE II FOR RISK STRATIFICATION FOR OFFPUMP CABG (OPCAB). â?? A PROSPECTIVE PARALLEL GROUP OBSERVATIONAL STUDY.

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039652
Enrollment
100
Registered
2022-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: NIL: NIL Control Intervention1: EuroSCORE II: EUROPEAN SYSTEM FOR CARDIAC OPERATIVE RISK EVALUATION II

Sponsors

NONE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex aged > 35 years with coronary artery disease requiring off- pump Coronary Artery Bypass Grafting procedure under general anaesthesia

Exclusion criteria

Exclusion criteria: Patient refusal to enroll in the study Conversion from off pump to on pump CABG Psychiatric disorders Pacemaker/ICD in situ Patients who expired in the OR or within 24 h after surgical procedure or in whom the surgical procedure was aborted for any reasons.

Design outcomes

Primary

MeasureTime frame
POST OPERATIVE EXTUBATION TIMETimepoint: LESS THAN 6 HOURS

Secondary

MeasureTime frame
LENGTH OF ICU STAYTimepoint: LOW RISK 2 DAYS MODERATE RISK 2 TO 4 DAYS HIGH RISK MORE THAN 4 DAYS;POST OPERATIVE STAY IN HOSPITAL TIMETimepoint: LOW RISK WITH DISCHARGE WITHIN 5 DAYS MODERATE RISK WITH DISCHARGE FROM 5 TO 7 DAYS HIGH RISK WITH DISCHARGE MORE THAN 7 DAYS ;POST OPERATIVE VASOACTIVE DRUG SUPPORTTimepoint: LOW RISK WITH NO DRUGS MODERATE RISK WITH ONE VASOACTIVE DRUG HIGH RISK WITH TWO OR MORE VASOACTIVE DRUGS

Countries

India

Contacts

Public ContactPAVAN KUMAR DAMMALAPATI

INSTITUTE OF POST GRADUATE MEDICAL EDUCATION & RESEARCH

chaitali03@rediffmail.com8820488209

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026